Company Filing History:
4 out of 152 
3 out of 3 
2 out of 51 Years Active: 1997-2023
Title: Innovations of Kristiina Takkinen
Introduction
Kristiina Takkinen is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of immunotherapy, particularly in developing hypoallergenic polypeptides for treating allergies. With a total of 10 patents to her name, Takkinen's work is paving the way for advancements in allergy treatments.
Latest Patents
One of her latest patents is focused on recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy. This invention relates to specific modified Equ c 1 polypeptides that serve as hypoallergens for desensitizing individuals against horse allergies. The recombinant hypoallergenic polypeptide activates the release of histamine from basophils to a lesser degree than the wild type allergen. Another significant patent involves mutant polypeptides that are useful as hypoallergens, specifically mutant Bet v 1 proteins, which are aimed at desensitizing individuals against birch pollen allergies. This invention also includes vaccine formulations comprising such polypeptides and methods of vaccination against birch pollen allergy.
Career Highlights
Throughout her career, Kristiina Takkinen has worked with notable organizations, including Valtion Teknillinen Tutkimuskeskus and Desentum Oy. Her innovative research and development efforts have significantly impacted the field of allergy treatment.
Collaborations
Takkinen has collaborated with esteemed colleagues such as Hans Söderlund and Juha Rouvinen, contributing to her success in the field.
Conclusion
Kristiina Takkinen's work in developing hypoallergenic polypeptides showcases her dedication to improving allergy treatments. Her innovative patents and collaborations highlight her significant role in advancing immunotherapy.